| Primary |
| Breast Cancer |
67.5% |
| Hypertension |
5.6% |
| Neoplasm Malignant |
4.3% |
| Breast Cancer Metastatic |
4.3% |
| Breast Cancer Female |
2.7% |
| Pain |
2.1% |
| Metastases To Bone |
1.4% |
| Osteoporosis |
1.4% |
| Depression |
1.3% |
| Diabetes Mellitus |
1.1% |
| Hypercholesterolaemia |
1.0% |
| Hypothyroidism |
1.0% |
| Blood Cholesterol Increased |
0.9% |
| Breast Cancer Recurrent |
0.9% |
| Chemotherapy |
0.9% |
| Thyroid Disorder |
0.8% |
| Ovulation Induction |
0.8% |
| Atrial Fibrillation |
0.7% |
| Constipation |
0.7% |
| Anxiety |
0.7% |
|
| Death |
27.5% |
| Weight Increased |
8.2% |
| Visual Acuity Reduced |
5.9% |
| Neoplasm Malignant |
5.2% |
| Pain In Extremity |
4.9% |
| Pneumonia |
4.3% |
| Vomiting |
4.1% |
| Pain |
3.8% |
| Malignant Neoplasm Progression |
3.6% |
| Surgery |
3.3% |
| Weight Decreased |
3.3% |
| Arthralgia |
3.2% |
| Myalgia |
3.2% |
| White Blood Cell Count Decreased |
3.0% |
| Dysphagia |
2.9% |
| Visual Impairment |
2.9% |
| Myocardial Infarction |
2.8% |
| Macular Degeneration |
2.6% |
| Nausea |
2.6% |
| Thrombocytopenia |
2.6% |
|
| Secondary |
| Breast Cancer |
41.0% |
| Product Used For Unknown Indication |
17.4% |
| Breast Cancer Metastatic |
9.7% |
| Metastases To Bone |
8.6% |
| Hypertension |
3.3% |
| Breast Cancer Female |
2.1% |
| Osteoporosis |
2.1% |
| Drug Use For Unknown Indication |
2.1% |
| Constipation |
1.7% |
| Depression |
1.7% |
| Pain |
1.5% |
| Breast Cancer Recurrent |
1.4% |
| Dermatomyositis |
1.4% |
| Diabetes Mellitus |
1.3% |
| Gastritis |
1.2% |
| Osteomyelitis |
1.0% |
| Chronic Hepatitis |
0.8% |
| Hypothyroidism |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Anaemia |
0.5% |
|
| Malignant Neoplasm Progression |
12.9% |
| Neoplasm Progression |
11.2% |
| Osteonecrosis |
7.7% |
| Vomiting |
7.7% |
| Tooth Extraction |
6.4% |
| Weight Decreased |
5.6% |
| Death |
4.7% |
| Toothache |
4.7% |
| Weight Increased |
4.7% |
| Cataract |
3.9% |
| Disease Progression |
3.9% |
| Wheezing |
3.4% |
| Alopecia |
3.0% |
| Oedema Peripheral |
3.0% |
| Pain |
3.0% |
| Pyrexia |
3.0% |
| Stridor |
3.0% |
| Visual Acuity Reduced |
3.0% |
| Arthralgia |
2.6% |
| Pancytopenia |
2.6% |
|
| Concomitant |
| Breast Cancer |
27.9% |
| Metastases To Bone |
16.4% |
| Breast Cancer Metastatic |
9.8% |
| Product Used For Unknown Indication |
8.0% |
| Drug Use For Unknown Indication |
5.6% |
| Pain |
4.9% |
| Depression |
4.7% |
| Osteoporosis |
4.0% |
| Hypertension |
3.2% |
| Prophylaxis |
2.5% |
| Breast Cancer Recurrent |
1.8% |
| Anxiety |
1.8% |
| Diabetes Mellitus |
1.6% |
| Insomnia |
1.3% |
| Nausea |
1.3% |
| Hypercalcaemia |
1.2% |
| Breast Cancer Female |
1.1% |
| Sleep Disorder |
1.1% |
| Arthritis |
1.0% |
| Muscle Spasms |
1.0% |
|
| Weight Decreased |
12.6% |
| Vomiting |
12.5% |
| Tooth Extraction |
11.5% |
| Osteonecrosis |
7.9% |
| Toothache |
6.9% |
| Weight Increased |
5.4% |
| Pain |
4.8% |
| Osteonecrosis Of Jaw |
4.0% |
| Wound Infection Staphylococcal |
3.5% |
| Wound Drainage |
3.4% |
| Urinary Tract Infection |
3.2% |
| Wound Debridement |
3.2% |
| Wound Dehiscence |
3.1% |
| Death |
3.0% |
| Thrombocytopenia |
2.7% |
| Breast Cancer |
2.5% |
| White Blood Cell Count Increased |
2.5% |
| White Blood Cell Count Decreased |
2.4% |
| Dyspnoea |
2.3% |
| Nausea |
2.3% |
|
| Interacting |
| Bipolar Disorder |
22.2% |
| Breast Cancer |
22.2% |
| Diabetes Mellitus |
22.2% |
| Dyslipidaemia |
11.1% |
| Hormone Therapy |
11.1% |
| Type 1 Diabetes Mellitus |
11.1% |
|
| Arterial Thrombosis |
20.0% |
| Breast Cancer |
20.0% |
| Drug Interaction |
20.0% |
| Drug Level Decreased |
20.0% |
| Potentiating Drug Interaction |
20.0% |
|
